down arrow

Syncom Formul.

Part of MojoOne Strategy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
16.85
0.51 (3.12%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.11 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

16.6517.72

52 Week

11.0027.94
Valuation
Technical
Day's Volume

CASH

17.11 lacs (-22.31%) Volume

Shareholding (Dec 2024)

FII

0.13%

Held by 7 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

50.57%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -80.90% and Operating profit at -73.21% over the last 5 years

 
2

Stock is technically in a Bearish range

3

With ROE of 11.5, it has a Expensive valuation with a 5.3 Price to Book Value

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,584 Cr (Small Cap)

stock-summary
P/E

39.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.21

stock-summary
Return on Equity

11.51%

stock-summary
Price to Book

5.33

Revenue and Profits (1 Year):
Net Sales:
128 Cr
(Quarterly Results - Dec 2024)
Net Profit:
13 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-22.1%
0%
-22.1%
1 Year
27.17%
0%
27.17%
2 Years
158.44%
0%
158.44%
3 Years
42.19%
0.35%
42.54%
4 Years
397.05%
0.47%
397.52%
5 Years
1859.3%
3.41%
1862.71%

Latest dividend: 0.03 per share ex-dividend date: Sep-09-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-80.90%
EBIT Growth (5y)
-73.21%
EBIT to Interest (avg)
17.38
Debt to EBITDA (avg)
1.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
16.80
Tax Ratio
25.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.13%
ROCE (avg)
127.82%
ROE (avg)
204.14%
Valuation key factors
Factor
Value
P/E Ratio
39
Industry P/E
33
Price to Book Value
5.33
EV to EBIT
36.39
EV to EBITDA
32.25
EV to Capital Employed
6.45
EV to Sales
3.78
PEG Ratio
0.81
Dividend Yield
NA
ROCE (Latest)
14.44%
ROE (Latest)
11.51%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 7 FIIs (0.13%)

Promoter with highest holding

Kedarmal Shankarlal Bankda (12.44%)

Highest Public shareholder

None

Individual Investors Holdings

45.06%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 24.65% vs 18.57% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 17.01% vs 45.61% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "127.53",
          "val2": "102.31",
          "chgp": "24.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.73",
          "val2": "12.16",
          "chgp": "21.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.16",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.00",
          "val2": "11.11",
          "chgp": "17.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.55%",
          "val2": "11.89%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 52.50% vs -98.83% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 71.86% vs -98.54% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "188.60",
          "val2": "123.67",
          "chgp": "52.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.65",
          "val2": "12.86",
          "chgp": "68.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.55",
          "val2": "2.20",
          "chgp": "-75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.75",
          "val2": "10.91",
          "chgp": "71.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.48%",
          "val2": "10.40%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 67.43% vs -98.23% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 77.28% vs -97.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "316.13",
          "val2": "188.81",
          "chgp": "67.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "36.38",
          "val2": "20.22",
          "chgp": "79.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.75",
          "val2": "3.28",
          "chgp": "-77.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.02",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.75",
          "val2": "17.91",
          "chgp": "77.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.51%",
          "val2": "10.71%",
          "chgp": "0.80%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 17.45% vs -98.98% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 26.11% vs -98.99% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "263.39",
          "val2": "224.25",
          "chgp": "17.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.65",
          "val2": "19.63",
          "chgp": "51.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.47",
          "val2": "3.13",
          "chgp": "42.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.02",
          "val2": "0.01",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.31",
          "val2": "20.07",
          "chgp": "26.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.26%",
          "val2": "8.75%",
          "chgp": "2.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
127.53
102.31
24.65%
Operating Profit (PBDIT) excl Other Income
14.73
12.16
21.13%
Interest
0.20
0.16
25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.00
11.11
17.01%
Operating Profit Margin (Excl OI)
11.55%
11.89%
-0.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 24.65% vs 18.57% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 17.01% vs 45.61% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
188.60
123.67
52.50%
Operating Profit (PBDIT) excl Other Income
21.65
12.86
68.35%
Interest
0.55
2.20
-75.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18.75
10.91
71.86%
Operating Profit Margin (Excl OI)
11.48%
10.40%
1.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 52.50% vs -98.83% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 71.86% vs -98.54% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
316.13
188.81
67.43%
Operating Profit (PBDIT) excl Other Income
36.38
20.22
79.92%
Interest
0.75
3.28
-77.13%
Exceptional Items
0.00
-0.02
100.00%
Consolidate Net Profit
31.75
17.91
77.28%
Operating Profit Margin (Excl OI)
11.51%
10.71%
0.80%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 67.43% vs -98.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 77.28% vs -97.61% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
263.39
224.25
17.45%
Operating Profit (PBDIT) excl Other Income
29.65
19.63
51.04%
Interest
4.47
3.13
42.81%
Exceptional Items
-0.02
0.01
-300.00%
Consolidate Net Profit
25.31
20.07
26.11%
Operating Profit Margin (Excl OI)
11.26%
8.75%
2.51%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 17.45% vs -98.98% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 26.11% vs -98.99% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Syncom Formulations (India) Ltd stock-summary
stock-summary
Syncom Formulations (India) Ltd
Small Cap
Pharmaceuticals & Drugs
Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Company Coordinates stock-summary
Company Details
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd Mumbai Maharashtra : 400093
stock-summary
Tel: 91-22-30887744
stock-summary
http://www.sfil.in
stock-summary
info@sfil.in / finance@sfil.in
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."